Related Experiment Video
Updated: May 16, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
High-density lipoproteins and myocardial necrosis in patients with acute myocardial infarction and ST segment
Ó Fabregat-Andrés1, M Ferrando-Beltrán, E Lucas-Inarejos
1Servicio de Cardiología, Consorcio Hospital General Universitario de Valencia, Valencia, Spain. osfan@comv.es
Insights
Low high-density lipoprotein cholesterol (HDLC) is common in ST-segment elevation myocardial infarction (STEMI) patients. Lower HDLC levels correlate with more extensive myocardial necrosis and reduced left ventricular ejection fraction (LVEF) after STEMI.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Low high-density lipoprotein cholesterol (HDLC) is a known prognostic factor in acute coronary syndrome.
- Understanding HDLC's role in myocardial injury post-STEMI is crucial for risk stratification.
Purpose of the Study:
- To investigate the association between HDLC levels and the extent of myocardial necrosis.
- To evaluate the impact of HDLC on left ventricular ejection fraction (LVEF) in STEMI patients.
Main Methods:
- Retrospective analysis of 139 patients with STEMI who underwent cardiac magnetic resonance (CMR) imaging.
- Assessment of myocardial necrosis using late gadolinium enhancement (LVEF) and measurement of LVEF.
Main Results:
- Patients with HDLC ≤40 mg/dl exhibited significantly larger areas of myocardial necrosis (RTG transmural pattern and percentage of total mass).
- Lower HDLC levels were associated with a significantly worse LVEF (49.7% vs. 57.2%).
- The majority of STEMI patients (69%) presented with low HDLC levels.
Conclusions:
- Low HDLC is prevalent in STEMI patients and linked to increased myocardial necrosis.
- Reduced HDLC is associated with impaired left ventricular function post-STEMI, as evidenced by CMR findings.
Introduction And Aim:
Low plasma levels of high-density lipoprotein cholesterol (HDLC) is a prognostic factor in patients with acute coronary syndrome. The aim of this study was to evaluate the relationship between HDLC and myocardial necrosis estimated by cardiac magnetic resonance (CMR) in patients with acute ST-segment elevation myocardial infarction (STEMI) and reperfusion strategy.
Methods:
Retrospective analysis of 139 patients (mean age 59.8 years; 79% men) admitted with STEMI who underwent a CMR in the first week.
Results:
With a comparable reperfusion strategy used and time of ischemia, patients with HDLC ≤40 mg/dl (69% of total) had more extensive areas of myocardial necrosis after STEMI, in number of segments with late gadolinium enhancement (RTG) with transmural necrosis pattern (4.7 vs. 2.1%, p < .001) and in percentage of RTG with respect to total mass myocardial (18.2 vs. 11.3%, p < .01), and worst left ventricular ejection fraction (LVEF) (49.7 vs. 57.2%, p < .001).
Conclusions:
We conclude that low HDLC are very common in patients with STEMI and associated with increased necrosis and a worse LVEF in the CRM study.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Myocarditis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Myocarditis II: Clinical Features and Diagnostic Tests
